All News

02-16 National Donor Day Spotlight: DaVita Patient Care Technician Donates Kidney AQ
02-13 Three hurt working on Exxon Beaumont, Texas small CDU, sources say RE
02-05 Truist Raises Price Target on DaVita to $158 From $128, Keeps Hold Rating MT
02-05 Analyst recommendations: Corteva, Snap, Alphabet, Eli Lilly, PayPal, Qualcomm… Zonebourse
02-04 TD Cowen Adjusts DaVita Price Target to $144 From $133, Maintains Hold Rating MT
02-04 UBS Adjusts Price Target on DaVita to $190 From $186, Maintains Buy Rating MT
02-03 US Equity Markets Lower Amid Technology-Led Selloff MT
02-03 Couchbase, Inc. Announces Executive Appointments CI
02-03 Barclays Adjusts Price Target on DaVita to $158 From $143 MT
02-02 Berkshire Hathaway Inc reports open market sale of 1,658,480 DaVita's common shares on Jan 29 at $120.5561/share RE
02-02 DaVita Inc., Q4 2025 Earnings Call, Feb 02, 2026
02-02 DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump RE
02-02 DaVita Q4 Adjusted Earnings Rise, Revenue Rises; Shares Jump After Hours MT
02-02 Davita announces 4th quarter 2025 results RE
02-02 DaVita Q4 Adjusted Earnings, Revenue Rise; Sets Outlook MT
02-02 Earnings Flash (DVA) DaVita Inc. Reports Q4 Revenue $3.62B, vs. FactSet Est of $3.51B MT
02-02 Earnings Flash (DVA) DaVita Inc. Posts Q4 Adjusted EPS $3.40 per Share, vs. FactSet Est of $3.24 MT
02-02 Tranche Update on DaVita Inc.'s Equity Buyback Plan announced on May 1, 2024. CI
02-02 Tranche Update on DaVita Inc.'s Equity Buyback Plan announced on December 10, 2020. CI
02-02 DaVita Inc. 4th Quarter 2025 Results PR
02-02 DaVita Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
02-02 Sector Update: Financial Stocks Advance Late Afternoon MT
02-02 Sector Update: Financial MT
02-02 Ares Management, DaVita to Invest in Elara Caring MT
02-01 Elara Caring announced that it expects to receive funding from DaVita Inc., Ares Management Corporation CI
No results for this search